Rheumatologists News and Research

RSS

Why doctors keep monitoring kids who recover from mysterious COVID-linked illness

Israel Shippy doesn’t remember much about having COVID-19 — or the unusual auto-immune disease it triggered — other than being groggy and uncomfortable for a bunch of days. He’s a 5-year-old, and would much rather talk about cartoons, or the ideas for inventions that constantly pop into his head.

16 Jul 2020

Methotrexate is not an additional risk factor for interstitial lung disease in RA patients

Patients with rheumatoid arthritis (RA) often suffer from what is referred to as interstitial lung disease (ILD).

7 Jul 2020

ACR releases position statement supporting the role of telemedicine in rheumatology

The American College of Rheumatology (ACR) has released an official position statement supporting the role of telemedicine as a tool with the potential to increase access and improve care for patients with rheumatic diseases.

29 Jun 2020

Deployment of health care professionals can improve inflammatory-rheumatic disorders

Inflammatory-rheumatic disorders are a widespread ailment, affecting at least 1.5 million people in Germany alone.

10 Jun 2020

EULAR publishes updated recommendations for treating people with psoriatic arthritis

The European League Against Rheumatism, EULAR, has published updated recommendations on the treatment of people with psoriatic arthritis.

27 May 2020

ACR warns about the economic impact of COVID-19 on rheumatology practices

In virtual meetings with lawmakers and on Twitter tomorrow, physician and health professional leaders from the American College of Rheumatology (ACR) are sounding the alarm about the economic impact of COVID-19 on rheumatology practices and the urgent need for more targeted relief that will help specialty practices remain solvent and continue to serve patients.

22 May 2020

Australian COVID-19 prevention trial begins for frontline and allied healthcare workers

COVID SHIELD is a major collaborative effort led by the Walter and Eliza Hall Institute of Medical Research in partnership with human data science company IQVIA.

19 May 2020

ACR releases new guideline for management of gout

Today, the American College of Rheumatology released the 2020 Guideline for the Management of Gout.

11 May 2020

EULAR publishes recommendations for management of rheumatic immune-related adverse events

The European League Against Rheumatism, EULAR, has published recommendations around rheumatic immune-related adverse events caused by cancer treatment with checkpoint inhibitors.

8 May 2020

EULAR launches database to monitor and report outcomes of COVID-19 in patients with RMDs

The European League Against Rheumatism launches a European pediatric and adult database to monitor and report outcomes of COVID-19 occurring in patients with rheumatic and musculoskeletal diseases with the support of the Global Rheumatology Alliance.

27 Mar 2020

COVID-19 Global Rheumatology Alliance launches registry to get data on rheumatic disease patients

Today, the COVID-19 Global Rheumatology Alliance launched an international registry to help collect data that will be used to guide rheumatology clinicians and health professionals as they assess and treat rheumatic disease patients who are, or may become, infected with the SARS-CoV-2 virus that causes COVID-19.

25 Mar 2020

Ultrasound could help reduce the use of drugs for patients with rheumatoid arthritis

A research group led by the physician Christian Dejaco is investigating circumstances under which patients may stop taking medication for rheumatoid arthritis without running the risk of the disease flaring up again.

20 Jan 2020

Updated guideline for management of osteoarthritis of the hand, hip and knee released

Today, the American College of Rheumatology, in partnership with the Arthritis Foundation, released the 2019 ACR/AF Guideline for the Management of Osteoarthritis of the Hand, Hip and Knee.

7 Jan 2020

The 2019 ACR/EULAR Classification Criteria for IgG4-Related Disease released

The American College of Rheumatology and the European League Against Rheumatism released the 2019 ACR/EULAR Classification Criteria for IgG4-Related Disease. It is the first criteria developed specifically for this recently recognized disease.

4 Dec 2019

Thermal imaging has potential to assess rheumatoid arthritis

A new study, published today in Scientific Reports, highlights that thermal imaging has the potential to become an important method to assess Rheumatoid Arthritis.

25 Nov 2019

Juvenile immune arthritis – new treatments wanted

Juvenile immune arthritis (JIA) is a severely undertreated condition, and new medications are badly needed to relieve the signs and symptoms of the illness, according to a new study presented at the 2019 ACR/ARP Annual Meeting.

11 Nov 2019

Lupus flare-ups could be linked to environmental factors

Researchers have found that alteration in the environment and atomospheric factors could be associated with organ specific flare-ups of lupus among patients diagnosed with Systemic Lupus Erethematosus (SLE). The study results were presented at the 2019 ACR/ARP Annual Meeting. The abstract was titled, “Environmental and Atmospheric Factors in Systemic Lupus Erythematosus: A Regression Analysis.”

11 Nov 2019

Gadolinium-enhanced MRI of shoulders helps predict recurrence of polymyalgia rheumatica

According to new research findings presented this week at the 2019 ACR/ARP Annual Meeting, use of gadolinium-enhanced magnetic resonance imaging (MRI) in shoulders of patients with polymyalgia rheumatica may contribute to more accurate diagnosis and prediction of recurrence.

11 Nov 2019

Research highlights benefits of oral prednisolone in patients with hand osteoarthritis

Research presented at the 2019 ACR/ARP Annual Meeting found that a six-week treatment with low-dose oral prednisolone substantially improves pain and decreases signs of inflammation in patients with painful hand osteoarthritis.

11 Nov 2019

Opioids do not improve quality of life or depression in OA patients

New research presented at the 2019 ACR/ARP Annual Meeting suggests that opioids contribute no measurable benefit to quality of life or depression for patients with osteoarthritis (OA).

11 Nov 2019

Rheumatologists News and Research

Why doctors keep monitoring kids who recover from mysterious COVID-linked illness

Methotrexate is not an additional risk factor for interstitial lung disease in RA patients

ACR releases position statement supporting the role of telemedicine in rheumatology

Deployment of health care professionals can improve inflammatory-rheumatic disorders

EULAR publishes updated recommendations for treating people with psoriatic arthritis

ACR warns about the economic impact of COVID-19 on rheumatology practices

Australian COVID-19 prevention trial begins for frontline and allied healthcare workers

ACR releases new guideline for management of gout

EULAR publishes recommendations for management of rheumatic immune-related adverse events

EULAR launches database to monitor and report outcomes of COVID-19 in patients with RMDs

COVID-19 Global Rheumatology Alliance launches registry to get data on rheumatic disease patients

Ultrasound could help reduce the use of drugs for patients with rheumatoid arthritis

Updated guideline for management of osteoarthritis of the hand, hip and knee released

The 2019 ACR/EULAR Classification Criteria for IgG4-Related Disease released

Thermal imaging has potential to assess rheumatoid arthritis

Juvenile immune arthritis – new treatments wanted

Lupus flare-ups could be linked to environmental factors

Gadolinium-enhanced MRI of shoulders helps predict recurrence of polymyalgia rheumatica

Research highlights benefits of oral prednisolone in patients with hand osteoarthritis

Opioids do not improve quality of life or depression in OA patients

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News